Apimeds Pharmaceuticals US, Inc. - Common stock, par value $0.01 per share (APUS) Institutional Ownership

CUSIP: 03771D102

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / Common stock, par value $0.01 per share
Symbol
APUS on NYSE
Shares outstanding
13,984,194
Price per share
$1.36
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
395,700
Total reported value
$648,947
% of total 13F portfolios
0%
Share change
-4,283
Value change
-$15,296
Number of holders
7
Price from insider filings
$1.36
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 03771D102?
CUSIP 03771D102 identifies APUS - Apimeds Pharmaceuticals US, Inc. - Common stock, par value $0.01 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Apimeds Pharmaceuticals US, Inc. - Common stock, par value $0.01 per share (APUS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Inscobee Inc. 34% -9.5% $8,460,571 -$139,336 4,316,618 -1.6% Apimeds Inc. 01 Dec 2025
Ayrton Capital LLC 10% $2,612,429 1,397,021 Ayrton Capital LLC 31 Dec 2025

As of 31 Dec 2025, 7 institutional investors reported holding 395,700 shares of Apimeds Pharmaceuticals US, Inc. - Common stock, par value $0.01 per share (APUS). This represents 2.8% of the company’s total 13,984,194 outstanding shares.

Institutional Holders of Apimeds Pharmaceuticals US, Inc. - Common stock, par value $0.01 per share (APUS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 395,700 $648,947 -$15,296 $1.64 7
2025 Q3 399,983 $711,810 +$221,594 $1.78 8
2025 Q2 278,531 $490,216 +$50,216 $1.76 6